Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants.

Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr. 2001 Feb; 138(2):198-204.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.